Reports

Vaccine Coverage - Third/Booster Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on THIRD/booster doses which are due, based on the booster dose schedule (6 months since second dose). * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
16 Nov 2021
Last updated
30 Nov 2021

OpenSAFELY COVID Vaccine coverage report: Booster / third doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Booster/Third doses

This report is intended to highlight any differences between subgroups of priority cohorts in receiving "booster" doses (or third primary doses where eligible), at least 6 months (27 weeks) after their second dose.

Report last updated 30 Nov 2021

Third dose vaccinations included up to 24 Nov 2021 inclusive

Only persons who had their second dose at least 27 weeks ago (19 May 2021) are included in the 'due' group.

Contents

Cumulative third dose vaccination figures among:

The above links will become functional as each of the stated populations are included in the report.

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Cumulative third dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,033,683 136,325 897,358 86.8 1,102,570
Sex F 594,853 86,604 508,249 85.4 636,706
M 438,823 49,721 389,102 88.7 465,864
Age band 80-84 548,898 59,675 489,223 89.1 582,652
85-89 325,087 44,422 280,665 86.3 346,535
90+ 159,691 32,235 127,456 79.8 173,376
Ethnicity (broad categories) Black 7,483 2,338 5,145 68.8 11,004
Mixed 2,576 574 2,002 77.7 3,304
Other 5,306 1,057 4,249 80.1 6,776
South Asian 22,638 5,747 16,891 74.6 28,420
Unknown 42,644 6,349 36,295 85.1 51,541
White 953,029 120,260 832,769 87.4 1,001,518
ethnicity 16 groups African 1,204 406 798 66.3 2,086
Bangladeshi or British Bangladeshi 903 364 539 59.7 1,302
Caribbean 5,355 1,673 3,682 68.8 7,511
Chinese 1,316 217 1,099 83.5 1,722
Other 3,976 826 3,150 79.2 5,047
Other Asian 3,493 798 2,695 77.2 4,466
British or Mixed British 906,059 113,113 792,946 87.5 949,046
Indian or British Indian 13,076 2,387 10,689 81.7 15,064
Irish 8,827 1,323 7,504 85.0 9,569
Other Black 924 259 665 72.0 1,407
Other White 38,136 5,831 32,305 84.7 42,896
Other mixed 973 175 798 82.0 1,176
Pakistani or British Pakistani 5,166 2,205 2,961 57.3 7,588
Unknown 42,665 6,349 36,316 85.1 51,562
White + Asian 462 84 378 81.8 546
White + Black African 252 70 182 72.2 385
White + Black Caribbean 889 245 644 72.4 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 125,237 24,150 101,087 80.7 140,224
2 168,952 26,250 142,702 84.5 183,225
3 232,757 30,681 202,076 86.8 247,310
4 243,054 28,441 214,613 88.3 255,892
5 Least deprived 244,811 24,465 220,346 90.0 255,388
Unknown 18,865 2,331 16,534 87.6 20,531
BMI 30+ 183,876 25,018 158,858 86.4 193,319
under 30 849,807 111,314 738,493 86.9 909,244
Housebound no 931,994 95,592 836,402 89.7 989,765
yes 101,689 40,740 60,949 59.9 112,798
Chronic cardiac disease no 719,103 90,552 628,551 87.4 770,938
yes 314,573 45,766 268,807 85.5 331,625
Current COPD no 924,294 119,462 804,832 87.1 987,133
yes 109,382 16,863 92,519 84.6 115,430
Dialysis no 1,031,744 135,975 895,769 86.8 1,100,498
yes 1,932 350 1,582 81.9 2,065
DMARDs no 1,000,650 132,013 868,637 86.8 1,068,074
yes 33,026 4,312 28,714 86.9 34,489
Dementia no 954,450 117,915 836,535 87.6 1,016,449
yes 79,233 18,417 60,816 76.8 86,114
Psychosis, schizophrenia, or bipolar no 1,026,536 134,603 891,933 86.9 1,094,380
yes 7,140 1,715 5,425 76.0 8,183
Learning disability no 1,033,235 136,171 897,064 86.8 1,102,059
yes 441 154 287 65.1 511
SSRI (last 12 months) no 992,159 129,738 862,421 86.9 1,058,953
yes 41,524 6,594 34,930 84.1 43,610
Chemo or radiotherapy no 997,339 131,957 865,382 86.8 1,064,595
yes 36,344 4,375 31,969 88.0 37,968
Cancer (lung) no 1,026,424 135,142 891,282 86.8 1,094,961
yes 7,259 1,190 6,069 83.6 7,602
Cancer (excluding lung/haem) no 841,519 112,833 728,686 86.6 901,761
yes 192,164 23,499 168,665 87.8 200,802
Cancer (haematological) no 1,013,999 133,917 880,082 86.8 1,081,955
yes 19,677 2,408 17,269 87.8 20,608

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 80+ Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,943,067 267,953 1,675,114 86.2 2,097,998
Sex F 1,019,788 144,634 875,154 85.8 1,100,582
M 923,279 123,326 799,953 86.6 997,402
Age band 70-74 1,099,868 169,526 930,342 84.6 1,198,687
75-79 843,199 98,427 744,772 88.3 899,297
Ethnicity (broad categories) Black 9,450 2,730 6,720 71.1 14,917
Mixed 5,033 1,036 3,997 79.4 6,643
Other 11,914 2,373 9,541 80.1 16,142
South Asian 44,870 10,647 34,223 76.3 57,064
Unknown 104,083 18,137 85,946 82.6 123,746
White 1,767,703 233,016 1,534,687 86.8 1,879,472
ethnicity 16 groups African 3,073 966 2,107 68.6 5,390
Bangladeshi or British Bangladeshi 1,316 553 763 58.0 1,890
Caribbean 4,606 1,330 3,276 71.1 6,860
Chinese 3,178 588 2,590 81.5 4,347
Other 8,715 1,778 6,937 79.6 11,781
Other Asian 9,044 1,904 7,140 78.9 11,627
British or Mixed British 1,682,569 219,975 1,462,594 86.9 1,779,491
Indian or British Indian 26,628 4,809 21,819 81.9 31,479
Irish 13,853 1,918 11,935 86.2 15,421
Other Black 1,764 434 1,330 75.4 2,667
Other White 71,281 11,123 60,158 84.4 84,560
Other mixed 2,044 413 1,631 79.8 2,604
Pakistani or British Pakistani 7,889 3,388 4,501 57.1 12,075
Unknown 104,097 18,137 85,960 82.6 123,753
White + Asian 1,183 210 973 82.2 1,428
White + Black African 749 189 560 74.8 1,106
White + Black Caribbean 1,071 231 840 78.4 1,512
Index of Multiple Deprivation (quintiles) 1 Most deprived 240,569 48,321 192,248 79.9 273,847
2 321,888 52,794 269,094 83.6 354,039
3 435,694 62,265 373,429 85.7 468,566
4 455,259 55,083 400,176 87.9 484,477
5 Least deprived 452,256 44,338 407,918 90.2 475,671
Unknown 37,394 5,159 32,235 86.2 41,384
BMI 30+ 488,313 73,136 415,177 85.0 519,036
under 30 1,454,747 194,817 1,259,930 86.6 1,578,948
Housebound no 1,907,906 253,316 1,654,590 86.7 2,056,908
yes 35,154 14,630 20,524 58.4 41,076
Chronic cardiac disease no 1,588,034 214,473 1,373,561 86.5 1,718,969
yes 355,026 53,473 301,553 84.9 379,015
Current COPD no 1,758,239 235,704 1,522,535 86.6 1,900,339
yes 184,821 32,242 152,579 82.6 197,645
Dialysis no 1,939,196 267,253 1,671,943 86.2 2,093,784
yes 3,871 700 3,171 81.9 4,200
DMARDs no 1,872,808 258,825 1,613,983 86.2 2,023,924
yes 70,252 9,121 61,131 87.0 74,060
Dementia no 1,903,874 258,671 1,645,203 86.4 2,054,997
yes 39,186 9,282 29,904 76.3 42,994
Psychosis, schizophrenia, or bipolar no 1,925,917 263,578 1,662,339 86.3 2,077,558
yes 17,143 4,368 12,775 74.5 20,426
Learning disability no 1,940,603 266,854 1,673,749 86.2 2,095,009
yes 2,457 1,099 1,358 55.3 2,982
SSRI (last 12 months) no 1,843,072 251,188 1,591,884 86.4 1,991,878
yes 99,988 16,758 83,230 83.2 106,106
Chemo or radiotherapy no 1,874,803 259,217 1,615,586 86.2 2,026,094
yes 68,257 8,729 59,528 87.2 71,890
Cancer (lung) no 1,930,523 265,713 1,664,810 86.2 2,084,621
yes 12,537 2,240 10,297 82.1 13,370
Cancer (excluding lung/haem) no 1,661,359 232,652 1,428,707 86.0 1,801,317
yes 281,701 35,301 246,400 87.5 296,674
Cancer (haematological) no 1,913,331 264,397 1,648,934 86.2 2,066,477
yes 29,729 3,556 26,173 88.0 31,507

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 70-79 Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among care home population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 95,844 15,309 80,535 84.0 109,900
Sex F 67,858 10,234 57,624 84.9 76,853
M 27,986 5,075 22,911 81.9 33,054
Age band 65-69 4,823 1,176 3,647 75.6 6,160
70-74 8,050 1,652 6,398 79.5 9,632
75-79 11,613 2,079 9,534 82.1 13,671
80-84 17,122 2,688 14,434 84.3 19,628
85-89 22,771 3,458 19,313 84.8 25,851
90+ 31,465 4,249 27,216 86.5 34,958
Ethnicity (broad categories) Black 490 98 392 80.0 707
Mixed 266 56 210 78.9 322
Other 427 63 364 85.2 511
South Asian 791 154 637 80.5 1,015
Unknown 2,009 266 1,743 86.8 2,429
White 91,868 14,679 77,189 84.0 104,909
Dementia no 42,826 7,721 35,105 82.0 50,498
yes 53,018 7,588 45,430 85.7 59,402

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Care Home Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 593,054 204,148 388,906 65.6 826,777
newly shielded since feb 15 no 403,760 113,253 290,507 72.0 486,829
yes 189,294 90,895 98,399 52.0 339,941
Sex F 327,999 113,211 214,788 65.5 465,885
M 265,048 90,937 174,111 65.7 360,878
Age band 16-29 36,610 18,823 17,787 48.6 66,878
30-39 70,574 33,943 36,631 51.9 125,972
40-49 108,507 44,247 64,260 59.2 165,564
50-59 174,153 56,847 117,306 67.4 229,544
60-69 203,210 50,295 152,915 75.2 238,812
Ethnicity (broad categories) Black 20,825 9,653 11,172 53.6 44,695
Mixed 7,742 3,304 4,438 57.3 14,357
Other 9,744 4,004 5,740 58.9 18,158
South Asian 58,730 27,699 31,031 52.8 107,947
Unknown 17,682 7,329 10,353 58.6 26,509
White 478,324 152,152 326,172 68.2 615,097
Index of Multiple Deprivation (quintiles) 1 Most deprived 152,040 64,638 87,402 57.5 241,556
2 129,388 47,929 81,459 63.0 186,165
3 118,804 38,619 80,185 67.5 157,332
4 98,084 27,629 70,455 71.8 123,837
5 Least deprived 79,541 19,859 59,682 75.0 96,229
Unknown 15,190 5,474 9,716 64.0 21,644
Learning disability no 572,684 196,182 376,502 65.7 799,848
yes 20,363 7,966 12,397 60.9 26,915

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Shielding (Aged 16-69) Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 872,368 230,125 642,243 73.6 1,087,107
Sex F 451,696 116,165 335,531 74.3 556,290
M 420,665 113,960 306,705 72.9 530,803
Ethnicity (broad categories) Black 6,013 2,212 3,801 63.2 11,585
Mixed 3,269 966 2,303 70.4 5,180
Other 7,588 2,240 5,348 70.5 12,607
South Asian 31,276 10,241 21,035 67.3 45,416
Unknown 60,116 18,739 41,377 68.8 87,507
White 764,099 195,720 568,379 74.4 924,798
ethnicity 16 groups African 2,233 847 1,386 62.1 4,613
Bangladeshi or British Bangladeshi 1,162 560 602 51.8 1,869
Caribbean 2,478 945 1,533 61.9 4,676
Chinese 2,408 721 1,687 70.1 4,046
Other 5,180 1,512 3,668 70.8 8,561
Other Asian 5,985 1,736 4,249 71.0 8,603
British or Mixed British 724,353 184,660 539,693 74.5 865,480
Indian or British Indian 18,130 4,893 13,237 73.0 23,765
Irish 5,320 1,267 4,053 76.2 6,748
Other Black 1,302 420 882 67.7 2,296
Other White 34,433 9,793 24,640 71.6 52,570
Other mixed 1,288 392 896 69.6 2,016
Pakistani or British Pakistani 5,992 3,052 2,940 49.1 11,186
Unknown 60,109 18,746 41,363 68.8 87,507
White + Asian 791 210 581 73.5 1,071
White + Black African 518 147 371 71.6 931
White + Black Caribbean 679 217 462 68.0 1,169
Index of Multiple Deprivation (quintiles) 1 Most deprived 110,131 35,189 74,942 68.0 155,036
2 146,818 43,463 103,355 70.4 191,016
3 194,649 53,060 141,589 72.7 240,674
4 202,307 49,686 152,621 75.4 243,019
5 Least deprived 199,934 43,897 156,037 78.0 233,744
Unknown 18,529 4,844 13,685 73.9 23,604
BMI 30+ 226,772 61,229 165,543 73.0 272,314
under 30 645,589 168,896 476,693 73.8 814,786
Housebound no 869,134 228,480 640,654 73.7 1,082,221
yes 3,234 1,652 1,582 48.9 4,879
Chronic cardiac disease no 777,210 203,812 573,398 73.8 972,951
yes 95,151 26,313 68,838 72.3 114,142
Current COPD no 838,978 220,052 618,926 73.8 1,046,311
yes 33,390 10,080 23,310 69.8 40,789
DMARDs no 854,756 225,834 628,922 73.6 1,066,562
yes 17,605 4,291 13,314 75.6 20,531
Dementia no 867,713 228,655 639,058 73.6 1,081,227
yes 4,655 1,477 3,178 68.3 5,866
Psychosis, schizophrenia, or bipolar no 864,409 227,129 637,280 73.7 1,075,333
yes 7,952 2,996 4,956 62.3 11,767
Learning disability no 870,723 229,320 641,403 73.7 1,084,580
yes 1,638 805 833 50.9 2,513
SSRI (last 12 months) no 820,533 214,942 605,591 73.8 1,024,464
yes 51,828 15,183 36,645 70.7 62,629
Chemo or radiotherapy no 855,267 225,813 629,454 73.6 1,066,891
yes 17,094 4,312 12,782 74.8 20,209
Cancer (lung) no 870,744 229,614 641,130 73.6 1,085,112
yes 1,617 511 1,106 68.4 1,981
Cancer (excluding lung/haem) no 795,256 211,323 583,933 73.4 996,590
yes 77,105 18,802 58,303 75.6 90,510
Cancer (haematological) no 869,232 229,383 639,849 73.6 1,083,348
yes 3,136 749 2,387 76.1 3,752

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 65-69 Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Summary

Third Doses due at 24 Nov (n) Third doses given (% of due) Third doses given (n) Third doses overdue (n) Total population
80+ 1,033,683 86.8 897,358 136,325 1,102,570
70-79 1,943,067 86.2 1,675,114 267,953 2,097,998
care home 95,844 84.0 80,535 15,309 109,900
shielding (aged 16-69) 593,054 65.6 388,906 204,148 826,777
65-69 872,368 73.6 642,243 230,125 1,087,107
LD (aged 16-64) 40,768 44.1 17,983 22,785 84,945
60-64 608,433 65.3 397,474 210,959 1,305,633
55-59 500,556 64.8 324,534 176,022 1,534,799
50-54 423,388 62.9 266,133 157,255 1,578,773

Vaccine Coverage - Third/Booster Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on THIRD/booster doses which are due, based on the booster dose schedule (6 months since second dose). * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
16 Nov 2021
Last updated
30 Nov 2021

OpenSAFELY COVID Vaccine coverage report: Booster / third doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Booster/Third doses

This report is intended to highlight any differences between subgroups of priority cohorts in receiving "booster" doses (or third primary doses where eligible), at least 6 months (27 weeks) after their second dose.

Report last updated 30 Nov 2021

Third dose vaccinations included up to 24 Nov 2021 inclusive

Only persons who had their second dose at least 27 weeks ago (19 May 2021) are included in the 'due' group.

Contents

Cumulative third dose vaccination figures among:

The above links will become functional as each of the stated populations are included in the report.

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Cumulative third dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,033,683 136,325 897,358 86.8 1,102,570
Sex F 594,853 86,604 508,249 85.4 636,706
M 438,823 49,721 389,102 88.7 465,864
Age band 80-84 548,898 59,675 489,223 89.1 582,652
85-89 325,087 44,422 280,665 86.3 346,535
90+ 159,691 32,235 127,456 79.8 173,376
Ethnicity (broad categories) Black 7,483 2,338 5,145 68.8 11,004
Mixed 2,576 574 2,002 77.7 3,304
Other 5,306 1,057 4,249 80.1 6,776
South Asian 22,638 5,747 16,891 74.6 28,420
Unknown 42,644 6,349 36,295 85.1 51,541
White 953,029 120,260 832,769 87.4 1,001,518
ethnicity 16 groups African 1,204 406 798 66.3 2,086
Bangladeshi or British Bangladeshi 903 364 539 59.7 1,302
Caribbean 5,355 1,673 3,682 68.8 7,511
Chinese 1,316 217 1,099 83.5 1,722
Other 3,976 826 3,150 79.2 5,047
Other Asian 3,493 798 2,695 77.2 4,466
British or Mixed British 906,059 113,113 792,946 87.5 949,046
Indian or British Indian 13,076 2,387 10,689 81.7 15,064
Irish 8,827 1,323 7,504 85.0 9,569
Other Black 924 259 665 72.0 1,407
Other White 38,136 5,831 32,305 84.7 42,896
Other mixed 973 175 798 82.0 1,176
Pakistani or British Pakistani 5,166 2,205 2,961 57.3 7,588
Unknown 42,665 6,349 36,316 85.1 51,562
White + Asian 462 84 378 81.8 546
White + Black African 252 70 182 72.2 385
White + Black Caribbean 889 245 644 72.4 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 125,237 24,150 101,087 80.7 140,224
2 168,952 26,250 142,702 84.5 183,225
3 232,757 30,681 202,076 86.8 247,310
4 243,054 28,441 214,613 88.3 255,892
5 Least deprived 244,811 24,465 220,346 90.0 255,388
Unknown 18,865 2,331 16,534 87.6 20,531
BMI 30+ 183,876 25,018 158,858 86.4 193,319
under 30 849,807 111,314 738,493 86.9 909,244
Housebound no 931,994 95,592 836,402 89.7 989,765
yes 101,689 40,740 60,949 59.9 112,798
Chronic cardiac disease no 719,103 90,552 628,551 87.4 770,938
yes 314,573 45,766 268,807 85.5 331,625
Current COPD no 924,294 119,462 804,832 87.1 987,133
yes 109,382 16,863 92,519 84.6 115,430
Dialysis no 1,031,744 135,975 895,769 86.8 1,100,498
yes 1,932 350 1,582 81.9 2,065
DMARDs no 1,000,650 132,013 868,637 86.8 1,068,074
yes 33,026 4,312 28,714 86.9 34,489
Dementia no 954,450 117,915 836,535 87.6 1,016,449
yes 79,233 18,417 60,816 76.8 86,114
Psychosis, schizophrenia, or bipolar no 1,026,536 134,603 891,933 86.9 1,094,380
yes 7,140 1,715 5,425 76.0 8,183
Learning disability no 1,033,235 136,171 897,064 86.8 1,102,059
yes 441 154 287 65.1 511
SSRI (last 12 months) no 992,159 129,738 862,421 86.9 1,058,953
yes 41,524 6,594 34,930 84.1 43,610
Chemo or radiotherapy no 997,339 131,957 865,382 86.8 1,064,595
yes 36,344 4,375 31,969 88.0 37,968
Cancer (lung) no 1,026,424 135,142 891,282 86.8 1,094,961
yes 7,259 1,190 6,069 83.6 7,602
Cancer (excluding lung/haem) no 841,519 112,833 728,686 86.6 901,761
yes 192,164 23,499 168,665 87.8 200,802
Cancer (haematological) no 1,013,999 133,917 880,082 86.8 1,081,955
yes 19,677 2,408 17,269 87.8 20,608

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 80+ Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,943,067 267,953 1,675,114 86.2 2,097,998
Sex F 1,019,788 144,634 875,154 85.8 1,100,582
M 923,279 123,326 799,953 86.6 997,402
Age band 70-74 1,099,868 169,526 930,342 84.6 1,198,687
75-79 843,199 98,427 744,772 88.3 899,297
Ethnicity (broad categories) Black 9,450 2,730 6,720 71.1 14,917
Mixed 5,033 1,036 3,997 79.4 6,643
Other 11,914 2,373 9,541 80.1 16,142
South Asian 44,870 10,647 34,223 76.3 57,064
Unknown 104,083 18,137 85,946 82.6 123,746
White 1,767,703 233,016 1,534,687 86.8 1,879,472
ethnicity 16 groups African 3,073 966 2,107 68.6 5,390
Bangladeshi or British Bangladeshi 1,316 553 763 58.0 1,890
Caribbean 4,606 1,330 3,276 71.1 6,860
Chinese 3,178 588 2,590 81.5 4,347
Other 8,715 1,778 6,937 79.6 11,781
Other Asian 9,044 1,904 7,140 78.9 11,627
British or Mixed British 1,682,569 219,975 1,462,594 86.9 1,779,491
Indian or British Indian 26,628 4,809 21,819 81.9 31,479
Irish 13,853 1,918 11,935 86.2 15,421
Other Black 1,764 434 1,330 75.4 2,667
Other White 71,281 11,123 60,158 84.4 84,560
Other mixed 2,044 413 1,631 79.8 2,604
Pakistani or British Pakistani 7,889 3,388 4,501 57.1 12,075
Unknown 104,097 18,137 85,960 82.6 123,753
White + Asian 1,183 210 973 82.2 1,428
White + Black African 749 189 560 74.8 1,106
White + Black Caribbean 1,071 231 840 78.4 1,512
Index of Multiple Deprivation (quintiles) 1 Most deprived 240,569 48,321 192,248 79.9 273,847
2 321,888 52,794 269,094 83.6 354,039
3 435,694 62,265 373,429 85.7 468,566
4 455,259 55,083 400,176 87.9 484,477
5 Least deprived 452,256 44,338 407,918 90.2 475,671
Unknown 37,394 5,159 32,235 86.2 41,384
BMI 30+ 488,313 73,136 415,177 85.0 519,036
under 30 1,454,747 194,817 1,259,930 86.6 1,578,948
Housebound no 1,907,906 253,316 1,654,590 86.7 2,056,908
yes 35,154 14,630 20,524 58.4 41,076
Chronic cardiac disease no 1,588,034 214,473 1,373,561 86.5 1,718,969
yes 355,026 53,473 301,553 84.9 379,015
Current COPD no 1,758,239 235,704 1,522,535 86.6 1,900,339
yes 184,821 32,242 152,579 82.6 197,645
Dialysis no 1,939,196 267,253 1,671,943 86.2 2,093,784
yes 3,871 700 3,171 81.9 4,200
DMARDs no 1,872,808 258,825 1,613,983 86.2 2,023,924
yes 70,252 9,121 61,131 87.0 74,060
Dementia no 1,903,874 258,671 1,645,203 86.4 2,054,997
yes 39,186 9,282 29,904 76.3 42,994
Psychosis, schizophrenia, or bipolar no 1,925,917 263,578 1,662,339 86.3 2,077,558
yes 17,143 4,368 12,775 74.5 20,426
Learning disability no 1,940,603 266,854 1,673,749 86.2 2,095,009
yes 2,457 1,099 1,358 55.3 2,982
SSRI (last 12 months) no 1,843,072 251,188 1,591,884 86.4 1,991,878
yes 99,988 16,758 83,230 83.2 106,106
Chemo or radiotherapy no 1,874,803 259,217 1,615,586 86.2 2,026,094
yes 68,257 8,729 59,528 87.2 71,890
Cancer (lung) no 1,930,523 265,713 1,664,810 86.2 2,084,621
yes 12,537 2,240 10,297 82.1 13,370
Cancer (excluding lung/haem) no 1,661,359 232,652 1,428,707 86.0 1,801,317
yes 281,701 35,301 246,400 87.5 296,674
Cancer (haematological) no 1,913,331 264,397 1,648,934 86.2 2,066,477
yes 29,729 3,556 26,173 88.0 31,507

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 70-79 Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among care home population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 95,844 15,309 80,535 84.0 109,900
Sex F 67,858 10,234 57,624 84.9 76,853
M 27,986 5,075 22,911 81.9 33,054
Age band 65-69 4,823 1,176 3,647 75.6 6,160
70-74 8,050 1,652 6,398 79.5 9,632
75-79 11,613 2,079 9,534 82.1 13,671
80-84 17,122 2,688 14,434 84.3 19,628
85-89 22,771 3,458 19,313 84.8 25,851
90+ 31,465 4,249 27,216 86.5 34,958
Ethnicity (broad categories) Black 490 98 392 80.0 707
Mixed 266 56 210 78.9 322
Other 427 63 364 85.2 511
South Asian 791 154 637 80.5 1,015
Unknown 2,009 266 1,743 86.8 2,429
White 91,868 14,679 77,189 84.0 104,909
Dementia no 42,826 7,721 35,105 82.0 50,498
yes 53,018 7,588 45,430 85.7 59,402

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Care Home Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 593,054 204,148 388,906 65.6 826,777
newly shielded since feb 15 no 403,760 113,253 290,507 72.0 486,829
yes 189,294 90,895 98,399 52.0 339,941
Sex F 327,999 113,211 214,788 65.5 465,885
M 265,048 90,937 174,111 65.7 360,878
Age band 16-29 36,610 18,823 17,787 48.6 66,878
30-39 70,574 33,943 36,631 51.9 125,972
40-49 108,507 44,247 64,260 59.2 165,564
50-59 174,153 56,847 117,306 67.4 229,544
60-69 203,210 50,295 152,915 75.2 238,812
Ethnicity (broad categories) Black 20,825 9,653 11,172 53.6 44,695
Mixed 7,742 3,304 4,438 57.3 14,357
Other 9,744 4,004 5,740 58.9 18,158
South Asian 58,730 27,699 31,031 52.8 107,947
Unknown 17,682 7,329 10,353 58.6 26,509
White 478,324 152,152 326,172 68.2 615,097
Index of Multiple Deprivation (quintiles) 1 Most deprived 152,040 64,638 87,402 57.5 241,556
2 129,388 47,929 81,459 63.0 186,165
3 118,804 38,619 80,185 67.5 157,332
4 98,084 27,629 70,455 71.8 123,837
5 Least deprived 79,541 19,859 59,682 75.0 96,229
Unknown 15,190 5,474 9,716 64.0 21,644
Learning disability no 572,684 196,182 376,502 65.7 799,848
yes 20,363 7,966 12,397 60.9 26,915

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Shielding (Aged 16-69) Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Third Doses due at 24 Nov (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 872,368 230,125 642,243 73.6 1,087,107
Sex F 451,696 116,165 335,531 74.3 556,290
M 420,665 113,960 306,705 72.9 530,803
Ethnicity (broad categories) Black 6,013 2,212 3,801 63.2 11,585
Mixed 3,269 966 2,303 70.4 5,180
Other 7,588 2,240 5,348 70.5 12,607
South Asian 31,276 10,241 21,035 67.3 45,416
Unknown 60,116 18,739 41,377 68.8 87,507
White 764,099 195,720 568,379 74.4 924,798
ethnicity 16 groups African 2,233 847 1,386 62.1 4,613
Bangladeshi or British Bangladeshi 1,162 560 602 51.8 1,869
Caribbean 2,478 945 1,533 61.9 4,676
Chinese 2,408 721 1,687 70.1 4,046
Other 5,180 1,512 3,668 70.8 8,561
Other Asian 5,985 1,736 4,249 71.0 8,603
British or Mixed British 724,353 184,660 539,693 74.5 865,480
Indian or British Indian 18,130 4,893 13,237 73.0 23,765
Irish 5,320 1,267 4,053 76.2 6,748
Other Black 1,302 420 882 67.7 2,296
Other White 34,433 9,793 24,640 71.6 52,570
Other mixed 1,288 392 896 69.6 2,016
Pakistani or British Pakistani 5,992 3,052 2,940 49.1 11,186
Unknown 60,109 18,746 41,363 68.8 87,507
White + Asian 791 210 581 73.5 1,071
White + Black African 518 147 371 71.6 931
White + Black Caribbean 679 217 462 68.0 1,169
Index of Multiple Deprivation (quintiles) 1 Most deprived 110,131 35,189 74,942 68.0 155,036
2 146,818 43,463 103,355 70.4 191,016
3 194,649 53,060 141,589 72.7 240,674
4 202,307 49,686 152,621 75.4 243,019
5 Least deprived 199,934 43,897 156,037 78.0 233,744
Unknown 18,529 4,844 13,685 73.9 23,604
BMI 30+ 226,772 61,229 165,543 73.0 272,314
under 30 645,589 168,896 476,693 73.8 814,786
Housebound no 869,134 228,480 640,654 73.7 1,082,221
yes 3,234 1,652 1,582 48.9 4,879
Chronic cardiac disease no 777,210 203,812 573,398 73.8 972,951
yes 95,151 26,313 68,838 72.3 114,142
Current COPD no 838,978 220,052 618,926 73.8 1,046,311
yes 33,390 10,080 23,310 69.8 40,789
DMARDs no 854,756 225,834 628,922 73.6 1,066,562
yes 17,605 4,291 13,314 75.6 20,531
Dementia no 867,713 228,655 639,058 73.6 1,081,227
yes 4,655 1,477 3,178 68.3 5,866
Psychosis, schizophrenia, or bipolar no 864,409 227,129 637,280 73.7 1,075,333
yes 7,952 2,996 4,956 62.3 11,767
Learning disability no 870,723 229,320 641,403 73.7 1,084,580
yes 1,638 805 833 50.9 2,513
SSRI (last 12 months) no 820,533 214,942 605,591 73.8 1,024,464
yes 51,828 15,183 36,645 70.7 62,629
Chemo or radiotherapy no 855,267 225,813 629,454 73.6 1,066,891
yes 17,094 4,312 12,782 74.8 20,209
Cancer (lung) no 870,744 229,614 641,130 73.6 1,085,112
yes 1,617 511 1,106 68.4 1,981
Cancer (excluding lung/haem) no 795,256 211,323 583,933 73.4 996,590
yes 77,105 18,802 58,303 75.6 90,510
Cancer (haematological) no 869,232 229,383 639,849 73.6 1,083,348
yes 3,136 749 2,387 76.1 3,752

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Third Doses Overdue Among 65-69 Population

Third doses which have not been given at least 27 weeks since the second dose

Error bars indicate possible error caused by rounding

Summary

Third Doses due at 24 Nov (n) Third doses given (% of due) Third doses given (n) Third doses overdue (n) Total population
80+ 1,033,683 86.8 897,358 136,325 1,102,570
70-79 1,943,067 86.2 1,675,114 267,953 2,097,998
care home 95,844 84.0 80,535 15,309 109,900
shielding (aged 16-69) 593,054 65.6 388,906 204,148 826,777
65-69 872,368 73.6 642,243 230,125 1,087,107
LD (aged 16-64) 40,768 44.1 17,983 22,785 84,945
60-64 608,433 65.3 397,474 210,959 1,305,633
55-59 500,556 64.8 324,534 176,022 1,534,799
50-54 423,388 62.9 266,133 157,255 1,578,773